# Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia

> **NCT00152594** · PHASE3 · TERMINATED · sponsor: **University of Cologne** · enrollment: 150 (—)

## Conditions studied

- Leukemia, Myelocytic, Acute

## Interventions

- **DRUG:** voriconazole

## Key facts

- **NCT ID:** NCT00152594
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 150 (—)
- **Last updated:** 2006-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152594, "Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00152594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*